427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Dexcom said CEO and Chairman Kevin R. Sayer is on a temporary medical leave effective September 14, 2025. The board named President and COO Jacob S. Leach as interim principal executive officer and Lead Independent Director Mark Foletta as interim chairman; neither will receive extra pay for the interim roles.
Kevin R. Sayer, CEO and Chairman, began a temporary medical leave effective September 14, 2025.
Jacob S. Leach, President and Chief Operating Officer, is interim principal executive officer in addition to his current duties.
Mark Foletta, Lead Independent Director, is interim chairman of the Board.
Leach and Foletta will not receive additional compensation for the interim appointments.
On September 11, 2025, Wingstop's board and compensation committee approved a one-time retention equity award for CEO Michael J. Skipworth, split into performance-based and service-based restricted stock units, each with a stated grant date value of $12.5 million. The company says the awards are meant to retain him and align his interests with stockholders, which is a compensation decision shareholders may weigh when assessing leadership continuity.
Award to CEO Michael J. Skipworth approved September 11, 2025 under the 2024 Omnibus Incentive Plan
45,505 performance-based RSUs with a $12.5 million grant date value; vesting from 0% to 100% based on system-wide sales targets over a 12-month period ending in fiscal Q2 2030
45,505 service-based RSUs with a $12.5 million grant date value; time-based vesting after five years
OTG Acquisition Corp. I, a blank-check company, closed its initial public offering on September 15, 2025, selling 23,000,000 units at $10.00 each for gross proceeds of $230,000,000, including the full exercise of the underwriters' over-allotment option. The filing says $231,150,000 of the proceeds was placed in a U.S. trust account, which is released to the company only when it completes a business combination or in certain redemption scenarios, so the funds remain set aside for a future acquisition.
IPO closed September 15, 2025: 23,000,000 units at $10.00 per unit, for gross proceeds of $230,000,000
$231,150,000 placed in a trust account maintained by Continental Stock Transfer & Trust Company
Concurrent private placement of 775,000 units for $7,750,000 to the sponsor and underwriters
Richard Nottenburg appointed to the board on September 12, 2025 and named chair of the Audit Committee; the company has 24 months from the IPO closing to complete a business combination
Cohen & Steers said Chief Financial Officer Raja Dakkuri will resign effective October 17, 2025, after securing another opportunity, and that the resignation was not due to any disagreement with the company. Controller Michael Donohue will become interim CFO on that date while keeping his controller role, and the company has started a search for a permanent successor. The filing does not report any financial results, but the change in the finance leadership team is relevant to shareholders.
Raja Dakkuri gave notice on September 11, 2025, and remains CFO through October 17, 2025.
Michael Donohue, Senior Vice President and Controller since May 2023, becomes interim CFO effective October 17, 2025.
Donohue's interim CFO bonus totals $300,000: $150,000 in cash payable in Q1 2026 and restricted stock units equal to $150,000 at the October 17, 2025 closing price, vesting over four years.
The company has begun a search for a permanent CFO that includes internal and external candidates.
Lindsay Corporation expanded its board from seven to eight members on September 15, 2025, and appointed Jahidul H. Khandaker as a director effective immediately. He will serve on the Audit Committee, and his term expires at the January 2026 annual meeting. The filing discloses no financial results, so the change is administrative and does not itself alter the company's financial outlook.
Board size increased from seven to eight members, effective September 15, 2025.
Mr. Khandaker, 54, is the GE HealthCare Chief Information Officer and previously held CIO roles at Western Digital.
He joins the Audit Committee; his director term expires at the January 2026 Annual Meeting.
He will receive director compensation as described in the November 20, 2024 proxy statement and has an indemnification agreement with the company.
Crown Castle said Christian H. Hillabrant began work as President and Chief Executive Officer on September 15, 2025, after the Board previously appointed him in an August 4, 2025 disclosure. The Board also expanded its size to 10 members and appointed him as a director effective the same day.
Christian H. Hillabrant became President and CEO and a director effective September 15, 2025.
The Board expanded from its prior size to 10 members, effective immediately before the appointment.
The filing states no arrangement with other persons for his board selection and no related party transactions reportable under Item 404(a).
Gap Inc. appointed Jody Gerson, Chairman and CEO of Universal Music Publishing Group, to its board effective September 15, 2025. The filing describes this as a board addition with compensation of $185,000 in stock units plus a pro rata share of the $95,000 annual cash retainer for fiscal 2025, and it contains no financial results or guidance.
Gerson appointed to the board effective September 15, 2025, with no arrangements with other persons tied to the appointment
Initial stock units valued at $185,000 based on fair market value at appointment
Pro rata share of the current $95,000 annual non-employee director cash retainer for fiscal 2025
Press release (Exhibit 99.1) furnished under Item 7.01 quotes CEO Richard Dickson and Board Chair Mayo A. Shattuck III
DoubleVerify said Chief Commercial Officer Julie Eddleman will resign effective December 31, 2025, and Chief Growth Officer Steve Mougis will become Global Chief Commercial Officer on January 1, 2026. Eddleman will stay on as a consultant and Senior Advisor for about six months, and the company has also announced related commercial leadership appointments.
Julie Eddleman resigns as EVP and Global Chief Commercial Officer effective December 31, 2025; the 8-K cites pursuit of other interests, and the press release says she intends to retire.
Steve Mougis, Chief Growth Officer and at DV Commercial since 2012, assumes the Global Chief Commercial Officer role on January 1, 2026.
Eddleman's consulting term runs about six months from January 1, 2026, at $350 per hour, and either party can end it on 30 days' notice.
Gian LaVecchia will become Chief Revenue Officer, and Joris Stevens will join as SVP, Global Account Management.
Harley-Davidson appointed Daniel J. Nova and Matthew J. Reintjes as independent directors effective September 15, 2025, while directors Sara Levinson and N. Thomas Linebarger retired from the board on the same date. The filing states the retirements were not the result of any disagreement with the company, and the board said the new members add finance, governance and brand expertise as Artie Starrs prepares to become CEO later this year.
Daniel J. Nova, a General Partner of Highland Capital Partners since 1999, joins the board and its Human Resources, Sustainability and Safety, and Nominating and Corporate Governance committees.
Matthew J. Reintjes, President and CEO of YETI Holdings since 2015, joins the board and its Audit and Finance and Nominating and Corporate Governance committees.
Each new director receives a $110,000 annual retainer pro-rated for service and an annual share unit grant of $145,000.
Levinson and Linebarger retired from the board effective September 15, 2025, after announcing their decisions on September 9 and September 10, 2025.
Research Frontiers announced that Michael R. LaPointe, Vice President – Aerospace Products, retired effective September 15, 2025. The company said he led expansion of its SPD-Smart aerospace programs and had more than 30 years of association with the company. The filing does not describe a successor or any financial impact.
Michael R. LaPointe, Vice President – Aerospace Products, retired effective September 15, 2025
LaPointe worked with Research Frontiers since 1994 and joined as an employee in 2000
Company says SPD-Smart EDWs have been contracted across five helicopter OEM programs, 12 aircraft OEM programs, an airline retrofit program, and more than 40 aftermarket aircraft models
The filing does not name a successor or provide financial results
Artivion entered into a Second Amendment to its Credit and Guaranty Agreement on September 12, 2025, with Ares Capital Corporation as administrative agent. The amendment extends the maturity of its existing term loans and revolving credit facility by one year to January 18, 2031, lowers the interest rate margins on those facilities, and adds a new $150.0 million secured delayed draw term loan. For shareholders, the filing shows added borrowing capacity and a longer repayment timeline, but also a new direct financial obligation tied to the company's debt.
Maturity of existing term loans and revolving credit facility extended one year to January 18, 2031
New $150.0 million secured delayed draw term loan available to borrow on or before September 12, 2027, subject to a maximum total net leverage ratio
Proceeds may fund permitted acquisitions, other permitted investments and capital expenditures
Prepayment premium of 1.00% applies to term loan prepayments made before July 18, 2027
On September 15, 2025, TKO Holdings amended its first lien credit agreement and borrowed the full $1.0 billion incremental term loan, maturing November 21, 2031. The proceeds are intended mainly to fund share repurchases, including $800.0 million under an accelerated share repurchase agreement with Morgan Stanley and up to $174.0 million under a 10b5-1 trading plan, which would leave the company with $1.0 billion remaining under its $2.0 billion repurchase program.
$1.0 billion incremental term loan borrowed September 15, 2025, priced at Term SOFR plus 2.00%
$800.0 million accelerated share repurchase with Morgan Stanley; $800.0 million payment due September 16, 2025, with completion expected December 2025
Up to $174.0 million in repurchases under a 10b5-1 plan, to start after the accelerated share repurchase is completed
Revolving credit facility maturity extended to September 15, 2030
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.